Set Your Location to See Relevant Information

Setting your location helps us to show you nearby providers and locations based on your healthcare needs.

Please note, because there is a high demand for COVID-19 vaccinations, appointments may not be immediately available. We thank you for your patience as we are working with the state and federal governments to ensure adequate supply to those eligible in Phases 1a and 1b.

Assessment of Primary Prevention Patients Receiving An ICD – Systematic Evaluation of ATP (APPRAISE ATP) (Protocol # C1924)

Study Details

The primary objective is to understand the role of antitachycardia pacing (ATP) in primary prevention patients indicated for ICD therapy and programmed according to current guidance of higher rate cut-offs and therapy delays. The time to first all-cause shock will be tested in subjects with standard therapy (ATP and shocks) compared to subjects programmed to shock only to assess equivalency.

Learn More

ClinicalTrials.gov NCT number
NCT02923726

Principal Investigators

  • Sandhya Dhruvakumar, MD
Sponsor(s)
Boston Scientific Corporation
Contact
Juan Garcia, RN at 203-358-8879
or officeofresearch@stamhealth.org

Our website uses cookies

This website uses cookies to give you the very best experience. Your continued use of this site is considered permission by you to use cookies in this manner. Please review our Privacy Policy and Terms of Use for more information about the data we collect and the types of cookies we use. Please note, if you link off our website to a 3rd party site of any kind, that website has its own terms and conditions.